Multi-Component ASD Supplement for Immune and Viral Modulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for autism spectrum disorder (ASD) primarily focus on managing symptoms without addressing underlying causes such as immune dysfunction and viral infections, and there is a need for integrated compositions and methods to improve cognitive, immune, and digestive functioning in individuals with ASD.

Innovation Solution

A supplement composition comprising tellimagrandin II, glycyrrhizin, monolaurin, selenium, omega-3 fatty acids, honokiol, and a probiotic (Bacillus coagulans BC-30), optionally with a biosurfactant like sophorolipid or surfactin, formulated for oral delivery to support immune health and suppress infectious agents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current medications are used to manage ASD symptoms, then behavioral symptoms may be improved, but underlying causes such as immune dysfunction and viral infections are not addressed

Engineering Contradiction:
Improveeffectiveness of treatmentVSAvoidcomprehensive treatment approach
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent combines multiple therapeutic components into a single composition that simultaneously addresses immune function, viral infection, and neurological health. This includes antiviral agents, immunomodulators, omega-3 fatty acids, and probiotics working together to provide comprehensive treatment that both manages symptoms and addresses underlying causes.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The treatment composition is designed to perform multiple functions simultaneously: suppressing viral infections, modulating immune response, supporting neurological development, and improving digestive health. This multi-functional approach allows a single intervention to address the diverse needs of individuals with ASD across different age groups.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If existing treatments focus on symptom management, then quality of life may improve, but cognitive and immune functioning are not enhanced

Engineering Contradiction:
Improvesymptom managementVSAvoidcognitive and immune support
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent employs a composite treatment formulation that integrates multiple active ingredients with complementary mechanisms of action. This composite approach includes antivirals for infection control, immunomodulators for immune balance, omega-3 fatty acids for neural support, and probiotics for gut health, creating a synergistic effect that enhances both symptom management and underlying functioning.

Inventive Principle:
Principle #40Composite materials

3Adaptability or versatility

If multiple separate treatments are used to address different ASD aspects, then comprehensive care is achieved, but treatment complexity increases

Engineering Contradiction:
Improvecomprehensive careVSAvoidtreatment regimen
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent consolidates multiple separate treatments into a single integrated composition that can be administered together. This unified formulation combines antiviral agents, immunomodulators, neurological supports, and probiotics into one regimen, reducing the number of separate medications and simplifying the treatment protocol while maintaining comprehensive coverage of all ASD-related concerns.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS12582148B2Compositions and methods for improving quality of life in patients with autism spectrum disorder
Publication Date: 2026.03.24 FLAASK LLC
  • US12582148B2 patent drawing

AI summary

The present invention provides compositions and methods for treating a subject diagnosed with ASD. In preferred embodiments, the subject compositions comprise tellimagrandin II, glycyrrhizin, monolaurin, selenium, honokiol, a probiotic, and one or more biological amphiphilic molecules, which when administered to a subject, can support immune and/or digestive health, and suppress and/or disable viral pathogenic agents in the body.